J9010 is the authoritative medical code for Injection, alemtuzumab, 10 mg. This classification is used in medical billing and clinical recording to specify the clinical criteria for injection, alemtuzumab, 10 mg (HCPCS Level II J9010), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Injection, alemtuzumab, 10 mg is a HCPCS Level II code J9010 for a Medicare-covered supply, service, or procedure. Short description: Alemtuzumab injection.
Codes in This Family (40)
Official HCPCS Level II classifications in the same code family as J9010, with their registry titles.
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9003 — Leuprolide injectable (camcevi etm), 1 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 — Injection, azacitidine, 1 mg
- J9026 — Injection, tarlatamab-dlle, 1 mg
- J9027 — Injection, clofarabine, 1 mg
- J9028 — Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029 — Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- J9030 — Bcg live intravesical instillation, 1 mg
- J9031 — Bcg (intravesical) per instillation
- J9032 — Injection, belinostat, 10 mg
- J9033 — Injection, bendamustine hydrochloride, 1 mg
- J9034 — Injection, bendamustine hcl (bendeka), 1 mg
- J9035 — Injection, bevacizumab, 10 mg
- J9036 — Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9037 — Injection, belantamab mafodotin-blmf, 0.5 mg
- J9038 — Injection, axatilimab-csfr, 0.1 mg
- J9039 — Injection, blinatumomab, 1 microgram
- J9040 — Injection, bleomycin sulfate, 15 units
- J9041 — Injection, bortezomib, 0.1 mg
- J9042 — Injection, brentuximab vedotin, 1 mg
- J9043 — Injection, cabazitaxel, 1 mg
- J9044 — Injection, bortezomib, not otherwise specified, 0.1 mg
- J9045 — Injection, carboplatin, 50 mg
- J9046 — Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
- J9047 — Injection, carfilzomib, 1 mg
- J9048 — Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
- J9049 — Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
- J9050 — Injection, carmustine, 100 mg
- J9051 — Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
- J9052 — Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
- J9053 — Injection, belantamab mafodotin-blmf, 0.1 mg
Related Codes & Numerical Sequence (Crawl Map)
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: